Gender Differences in Human Sepsis

BACKGROUND In animal studies, gender differences were related to hormonal and immunologic changes that were associated with an increased susceptibility to sepsis in males. OBJECTIVE In a prospective study, gender differences in patients with surgical sepsis were evaluated in terms of survival, sex h...

Full description

Saved in:
Bibliographic Details
Published inArchives of surgery (Chicago. 1960) Vol. 133; no. 11; pp. 1200 - 1205
Main Authors Schröder, Jörg, Kahlke, Volker, Staubach, Karl-Hermann, Zabel, Peter, Stüber, Frank
Format Journal Article
LanguageEnglish
Published United States American Medical Association 01.11.1998
Subjects
Online AccessGet full text

Cover

Loading…
Abstract BACKGROUND In animal studies, gender differences were related to hormonal and immunologic changes that were associated with an increased susceptibility to sepsis in males. OBJECTIVE In a prospective study, gender differences in patients with surgical sepsis were evaluated in terms of survival, sex hormones, and proinflammatory as well as anti-inflammatory mediators. SETTING Surgical intensive care unit of a university hospital. PATIENTS Fifty-two patients (19 women and 33 men) with surgical sepsis. MEASUREMENTS AND MAIN RESULTS In a prospective study, tumor necrosis factor α and interleukin 6 bioactivity and plasma levels of interleukin 10 (using enzyme-linked immunosorbent assay), total testosterone, and 17-β estradiol (using radioimmunoassay) were determined on days 1, 3, 5, 7, 10, and 14 after diagnosis of sepsis. There were no differences in characteristics of patients in age (mean age, 55.4 years for women and 53.1 years for men) or cause and severity of sepsis (Acute Physiology and Chronic Health Evaluation II score, 17.3 for women and 18.5 for men; multiple organ dysfunction score, 9.9 vs 10.8, respectively). Although no difference could be found in the multiple organ dysfunction score from day 1 to day 28, the prognosis of sepsis was significantly different in women compared with men. Hospital mortality rate was 70% (23 of 33 patients) in male and 26% (5 of 19) in female patients (P<.008, log-rank test). Bioactivity of tumor necrosis factor continuously increased in men after diagnosis of sepsis, with significantly elevated levels on day 10 (P<.05, Mann-Whitney U test with Bonferroni correction), whereas no difference was found for interleukin 6 bioactivity. Women displayed enhanced interleukin 10 levels compared with men from day 1 to day 10 that reached a significant difference on days 3 and 5 (P<.05). Total testosterone levels were below the normal range for men, and estradiol levels were initially increased in both men and postmenopausal women, with higher levels for women. CONCLUSIONS In this prospective study, gender differences were confirmed in human sepsis, with a significantly better prognosis for women, which may be related to increased levels of anti-inflammatory mediators. The hypothetical different ratio of proinflammatory and anti-inflammatory mediators may be important for further therapeutic interventions in sepsis.-->
AbstractList BACKGROUNDIn animal studies, gender differences were related to hormonal and immunologic changes that were associated with an increased susceptibility to sepsis in males.OBJECTIVEIn a prospective study, gender differences in patients with surgical sepsis were evaluated in terms of survival, sex hormones, and proinflammatory as well as anti-inflammatory mediators.SETTINGSurgical intensive care unit of a university hospital.PATIENTSFifty-two patients (19 women and 33 men) with surgical sepsis.MEASUREMENTS AND MAIN RESULTSIn a prospective study, tumor necrosis factor alpha and interleukin 6 bioactivity and plasma levels of interleukin 10 (using enzyme-linked immunosorbent assay), total testosterone, and 17-beta estradiol (using radioimmunoassay) were determined on days 1, 3, 5, 7, 10, and 14 after diagnosis of sepsis. There were no differences in characteristics of patients in age (mean age, 55.4 years for women and 53.1 years for men) or cause and severity of sepsis (Acute Physiology and Chronic Health Evaluation II score, 17.3 for women and 18.5 for men; multiple organ dysfunction score, 9.9 vs 10.8, respectively). Although no difference could be found in the multiple organ dysfunction score from day 1 to day 28, the prognosis of sepsis was significantly different in women compared with men. Hospital-mortality rate was 70% (23 of 33 patients) in male and 26% (5 of 19) in female patients (P<.008, log-rank test). Bioactivity of tumor necrosis factor continuously increased in men after diagnosis of sepsis, with significantly elevated levels on day 10 (P<.05, Mann-Whitney U test with Bonferroni correction), whereas no difference was found for interleukin 6 bioactivity. Women displayed enhanced interleukin 10 levels compared with men from day 1 to day 10 that reached a significant difference on days 3 and 5 (P<.05). Total testosterone levels were below the normal range for men, and estradiol levels were initially increased in both men and postmenopausal women, with higher levels for women.CONCLUSIONSIn this prospective study, gender differences were confirmed in human sepsis, with a significantly better prognosis for women, which may be related to increased levels of anti-inflammatory mediators. The hypothetical different ratio of proinflammatory and anti-inflammatory mediators may be important for further therapeutic interventions in sepsis.
In animal studies, gender differences were related to hormonal and immunologic changes that were associated with an increased susceptibility to sepsis in males. In a prospective study, gender differences in patients with surgical sepsis were evaluated in terms of survival, sex hormones, and proinflammatory as well as anti-inflammatory mediators. Surgical intensive care unit of a university hospital. Fifty-two patients (19 women and 33 men) with surgical sepsis. In a prospective study, tumor necrosis factor alpha and interleukin 6 bioactivity and plasma levels of interleukin 10 (using enzyme-linked immunosorbent assay), total testosterone, and 17-beta estradiol (using radioimmunoassay) were determined on days 1, 3, 5, 7, 10, and 14 after diagnosis of sepsis. There were no differences in characteristics of patients in age (mean age, 55.4 years for women and 53.1 years for men) or cause and severity of sepsis (Acute Physiology and Chronic Health Evaluation II score, 17.3 for women and 18.5 for men; multiple organ dysfunction score, 9.9 vs 10.8, respectively). Although no difference could be found in the multiple organ dysfunction score from day 1 to day 28, the prognosis of sepsis was significantly different in women compared with men. Hospital-mortality rate was 70% (23 of 33 patients) in male and 26% (5 of 19) in female patients (P<.008, log-rank test). Bioactivity of tumor necrosis factor continuously increased in men after diagnosis of sepsis, with significantly elevated levels on day 10 (P<.05, Mann-Whitney U test with Bonferroni correction), whereas no difference was found for interleukin 6 bioactivity. Women displayed enhanced interleukin 10 levels compared with men from day 1 to day 10 that reached a significant difference on days 3 and 5 (P<.05). Total testosterone levels were below the normal range for men, and estradiol levels were initially increased in both men and postmenopausal women, with higher levels for women. In this prospective study, gender differences were confirmed in human sepsis, with a significantly better prognosis for women, which may be related to increased levels of anti-inflammatory mediators. The hypothetical different ratio of proinflammatory and anti-inflammatory mediators may be important for further therapeutic interventions in sepsis.
BACKGROUND: In animal studies, gender differences were related to hormonal and immunologic changes that were associated with an increased susceptibility to sepsis in males. OBJECTIVE: In a prospective study, gender differences in patients with surgical sepsis were evaluated in terms of survival, sex hormones, and proinflammatory as well as anti-inflammatory mediators. SETTING: Surgical intensive care unit of a university hospital. PATIENTS: Fifty-two patients (19 women and 33 men) with surgical sepsis. MEASUREMENTS AND MAIN RESULTS: In a prospective study, tumor necrosis factor alpha and interleukin 6 bioactivity and plasma levels of interleukin 10 (using enzyme-linked immunosorbent assay), total testosterone, and 17-beta estradiol (using radioimmunoassay) were determined on days 1, 3, 5, 7, 10, and 14 after diagnosis of sepsis. There were no differences in characteristics of patients in age (mean age, 55.4 years for women and 53.1 years for men) or cause and severity of sepsis (Acute Physiology and Chronic Health Evaluation II score, 17.3 for women and 18.5 for men; multiple organ dysfunction score, 9.9 vs 10.8, respectively). Although no difference could be found in the multiple organ dysfunction score from day 1 to day 28, the prognosis of sepsis was significantly different in women compared with men. Hospital-mortality rate was 70% (23 of 33 patients) in male and 26% (5 of 19) in female patients (P<.008, log-rank test). Bioactivity of tumor necrosis factor continuously increased in men after diagnosis of sepsis, with significantly elevated levels on day 10 (P<.05, Mann-Whitney U test with Bonferroni correction), whereas no difference was found for interleukin 6 bioactivity. Women displayed enhanced interleukin 10 levels compared with men from day 1 to day 10 that reached a significant difference on days 3 and 5 (P<.05). Total testosterone levels were below the normal range for men, and estradiol levels were initially increased in both men and postmenopausal women, with higher levels for women. CONCLUSIONS: In this prospective study, gender differences were confirmed in human sepsis, with a significantly better prognosis for women, which may be related to increased levels of anti-inflammatory mediators. The hypothetical different ratio of proinflammatory and anti-inflammatory mediators may be important for further therapeutic interventions in sepsis.
BACKGROUND In animal studies, gender differences were related to hormonal and immunologic changes that were associated with an increased susceptibility to sepsis in males. OBJECTIVE In a prospective study, gender differences in patients with surgical sepsis were evaluated in terms of survival, sex hormones, and proinflammatory as well as anti-inflammatory mediators. SETTING Surgical intensive care unit of a university hospital. PATIENTS Fifty-two patients (19 women and 33 men) with surgical sepsis. MEASUREMENTS AND MAIN RESULTS In a prospective study, tumor necrosis factor α and interleukin 6 bioactivity and plasma levels of interleukin 10 (using enzyme-linked immunosorbent assay), total testosterone, and 17-β estradiol (using radioimmunoassay) were determined on days 1, 3, 5, 7, 10, and 14 after diagnosis of sepsis. There were no differences in characteristics of patients in age (mean age, 55.4 years for women and 53.1 years for men) or cause and severity of sepsis (Acute Physiology and Chronic Health Evaluation II score, 17.3 for women and 18.5 for men; multiple organ dysfunction score, 9.9 vs 10.8, respectively). Although no difference could be found in the multiple organ dysfunction score from day 1 to day 28, the prognosis of sepsis was significantly different in women compared with men. Hospital mortality rate was 70% (23 of 33 patients) in male and 26% (5 of 19) in female patients (P<.008, log-rank test). Bioactivity of tumor necrosis factor continuously increased in men after diagnosis of sepsis, with significantly elevated levels on day 10 (P<.05, Mann-Whitney U test with Bonferroni correction), whereas no difference was found for interleukin 6 bioactivity. Women displayed enhanced interleukin 10 levels compared with men from day 1 to day 10 that reached a significant difference on days 3 and 5 (P<.05). Total testosterone levels were below the normal range for men, and estradiol levels were initially increased in both men and postmenopausal women, with higher levels for women. CONCLUSIONS In this prospective study, gender differences were confirmed in human sepsis, with a significantly better prognosis for women, which may be related to increased levels of anti-inflammatory mediators. The hypothetical different ratio of proinflammatory and anti-inflammatory mediators may be important for further therapeutic interventions in sepsis.-->
Author Stüber, Frank
Staubach, Karl-Hermann
Zabel, Peter
Schröder, Jörg
Kahlke, Volker
Author_xml – sequence: 1
  givenname: Jörg
  surname: Schröder
  fullname: Schröder, Jörg
– sequence: 2
  givenname: Volker
  surname: Kahlke
  fullname: Kahlke, Volker
– sequence: 3
  givenname: Karl-Hermann
  surname: Staubach
  fullname: Staubach, Karl-Hermann
– sequence: 4
  givenname: Peter
  surname: Zabel
  fullname: Zabel, Peter
– sequence: 5
  givenname: Frank
  surname: Stüber
  fullname: Stüber, Frank
BackLink https://www.ncbi.nlm.nih.gov/pubmed/9820351$$D View this record in MEDLINE/PubMed
BookMark eNpdkE1LAzEQhoNUalv9AYLC0oO3XTP52CRHqdoKBQ_2HtLdRLd0szXpHvz3prT24GkG3ucdhmeMBr7zFqE7wAVgDI8mVF-xD58FUFoAFEAwvkAj4FTmtGRsgEYYY5YnFl-hcYybtBGpyBANlSSYchih6dz62obsuXHOBusrG7PGZ4u-NT77sLvYxGt06cw22pvTnKDV68tqtsiX7_O32dMyN1TRfQ51xY2DShJlS1JzxlRaOK6ZIap2kouydJjXXDq1pkKtLSO2qoThqcExnaCH49ld6L57G_e6bWJlt1vjbddHLTAWTFBI4PQfuOn64NNrmlDCuRBSJIgdoSp0MQbr9C40rQk_GrA-6NN_-nTSpwH0QV-q3Z9u9-vW1ufSyVfKb4-5ac05JACSSvoLiBl0kA
CitedBy_id crossref_primary_10_4161_viru_26982
crossref_primary_10_1016_j_steroids_2024_109426
crossref_primary_10_1080_07853890_2023_2244873
crossref_primary_10_1007_s10620_017_4554_6
crossref_primary_10_1124_jpet_105_090480
crossref_primary_10_1152_ajpendo_00279_2017
crossref_primary_10_1038_s41590_018_0211_2
crossref_primary_10_1016_S0303_7207_02_00106_5
crossref_primary_10_1016_j_neuroscience_2018_12_008
crossref_primary_10_3389_fpubh_2023_1235745
crossref_primary_10_1016_j_yhbeh_2012_02_005
crossref_primary_10_1016_j_jhep_2004_12_026
crossref_primary_10_1155_2010_485306
crossref_primary_10_1186_s41038_017_0093_9
crossref_primary_10_1371_journal_pone_0100631
crossref_primary_10_1097_SHK_0b013e31815c3ea0
crossref_primary_10_1016_j_ejcdt_2015_12_006
crossref_primary_10_1097_00005373_200209000_00007
crossref_primary_10_1111_cmi_13107
crossref_primary_10_1097_00005373_200209000_00006
crossref_primary_10_1016_S0039_6109_05_70084_0
crossref_primary_10_1097_SLA_0b013e3181dcf36e
crossref_primary_10_1007_s10096_013_1957_y
crossref_primary_10_1089_sur_2008_046
crossref_primary_10_1016_j_tmrv_2012_08_002
crossref_primary_10_1136_bmjopen_2020_040823
crossref_primary_10_3389_fpubh_2023_1143650
crossref_primary_10_1038_sj_bjc_6601099
crossref_primary_10_1097_NCC_0b013e318202520a
crossref_primary_10_1089_109629604773860282
crossref_primary_10_3390_jcm9010077
crossref_primary_10_1097_00001432_200006000_00004
crossref_primary_10_1038_s41467_020_19741_6
crossref_primary_10_1186_s13613_021_00807_7
crossref_primary_10_1016_j_domaniend_2011_01_003
crossref_primary_10_1016_j_ejim_2012_10_009
crossref_primary_10_1186_s41038_017_0083_y
crossref_primary_10_4049_jimmunol_1003652
crossref_primary_10_1186_s13741_020_00151_7
crossref_primary_10_1111_nicc_12280
crossref_primary_10_1186_s12906_022_03655_5
crossref_primary_10_1016_j_yjmcc_2009_05_002
crossref_primary_10_1007_s00595_007_3508_6
crossref_primary_10_1016_j_ajog_2008_12_032
crossref_primary_10_1164_rccm_200712_1895OC
crossref_primary_10_1164_rccm_200611_1712OC
crossref_primary_10_4049_jimmunol_1701677
crossref_primary_10_1038_s41598_023_49311_x
crossref_primary_10_1016_j_cellimm_2004_08_002
crossref_primary_10_1152_ajpheart_2000_279_3_H1015
crossref_primary_10_1378_chest_07_2001
crossref_primary_10_1097_01_CCM_0000227173_13497_56
crossref_primary_10_1016_S1348_8643_13_00009_8
crossref_primary_10_1164_ajrccm_165_6_2103038
crossref_primary_10_1097_01_CCM_0000278603_18687_4F
crossref_primary_10_1152_ajpcell_00091_2022
crossref_primary_10_1590_S0102_86502007000100004
crossref_primary_10_1016_j_jcrc_2019_09_023
crossref_primary_10_4055_cios21110
crossref_primary_10_1378_chest_125_1_203
crossref_primary_10_7759_cureus_9140
crossref_primary_10_18699_SSMJ20240120
crossref_primary_10_1177_0885066617719750
crossref_primary_10_1016_j_bbi_2020_05_037
crossref_primary_10_3390_microorganisms11030746
crossref_primary_10_1097_TA_0b013e31825a789b
crossref_primary_10_1177_00031348221087905
crossref_primary_10_1097_01_CCM_0000155991_88802_4D
crossref_primary_10_1002_prca_201300048
crossref_primary_10_1097_01_shk_0000148055_12387_15
crossref_primary_10_1016_j_jpeds_2013_04_018
crossref_primary_10_1007_s00108_008_2288_4
crossref_primary_10_1097_01_shk_0000135257_44570_39
crossref_primary_10_1095_biolreprod_110_085167
crossref_primary_10_1371_journal_pone_0213239
crossref_primary_10_1016_j_mce_2010_07_017
crossref_primary_10_1128_iai_00283_22
crossref_primary_10_1016_j_cyto_2003_10_006
crossref_primary_10_1097_00000658_200201000_00014
crossref_primary_10_1016_S1053_0770_00_90010_7
crossref_primary_10_1371_journal_pone_0067736
crossref_primary_10_1016_j_jaci_2009_02_019
crossref_primary_10_1097_SHK_0000000000001717
crossref_primary_10_1371_journal_pntd_0008737
crossref_primary_10_1097_01_BCR_0000225957_01854_EE
crossref_primary_10_4049_jimmunol_0903463
crossref_primary_10_3390_cells12071003
crossref_primary_10_1097_00003246_200103000_00015
crossref_primary_10_1097_TA_0b013e3182468989
crossref_primary_10_1359_jbmr_2003_18_12_2231
crossref_primary_10_1097_00005373_200102000_00013
crossref_primary_10_1097_CCM_0000000000003311
crossref_primary_10_1016_j_surg_2014_04_018
crossref_primary_10_1006_cyto_2002_1016
crossref_primary_10_1007_s10753_008_9075_1
crossref_primary_10_1111_prd_12033
crossref_primary_10_1016_S0271_5317_00_00284_0
crossref_primary_10_3390_pathogens12010109
crossref_primary_10_3748_wjg_v27_i28_4504
crossref_primary_10_1146_annurev_pharmtox_010919_023229
crossref_primary_10_1016_j_burns_2004_10_007
crossref_primary_10_3390_nu4030231
crossref_primary_10_1038_s41598_021_02815_w
crossref_primary_10_1186_s12610_016_0034_7
crossref_primary_10_1177_1753425917707026
crossref_primary_10_1186_1471_2466_14_128
crossref_primary_10_1189_jlb_0607360
crossref_primary_10_1016_j_steroids_2015_06_016
crossref_primary_10_1016_j_bbrc_2013_10_042
crossref_primary_10_1371_journal_pone_0231374
crossref_primary_10_1586_eci_11_51
crossref_primary_10_1016_j_jtcvs_2014_03_012
crossref_primary_10_1152_ajpheart_00694_2005
crossref_primary_10_1007_s00595_005_3044_1
crossref_primary_10_1016_j_jphs_2022_05_006
crossref_primary_10_1097_01_CCM_0000266534_14262_E8
crossref_primary_10_1111_j_1365_2354_2008_01036_x
crossref_primary_10_1016_S0899_9007_01_00588_3
crossref_primary_10_1007_s00392_011_0403_3
crossref_primary_10_1111_j_1399_6576_2005_00759_x
crossref_primary_10_1177_000313480006601001
crossref_primary_10_1002_hep_23782
crossref_primary_10_1097_TA_0b013e31823a06ea
crossref_primary_10_1189_jlb_70_6_887
crossref_primary_10_1016_j_jvoice_2022_07_024
crossref_primary_10_17221_7481_VETMED
crossref_primary_10_1016_j_jss_2005_07_039
crossref_primary_10_1189_jlb_1103589
crossref_primary_10_1097_MCC_0b013e3283307a12
crossref_primary_10_1097_CCM_0b013e3181a569df
crossref_primary_10_1016_j_jss_2007_12_777
crossref_primary_10_1172_JCI0215704
crossref_primary_10_1016_j_bbi_2008_10_001
crossref_primary_10_1186_s40001_024_01651_8
crossref_primary_10_1016_S0741_8329_02_00278_1
crossref_primary_10_1007_s00384_013_1647_3
crossref_primary_10_1097_01_CCM_0000261890_41311_E9
crossref_primary_10_1210_endo_143_7_8919
crossref_primary_10_1016_j_genm_2012_10_009
crossref_primary_10_1210_endo_141_4_7404
crossref_primary_10_1016_j_injury_2004_03_014
crossref_primary_10_1016_j_vaccine_2003_10_019
crossref_primary_10_1016_S0899_9007_00_00449_4
crossref_primary_10_3390_ijms21113861
crossref_primary_10_1016_j_jvs_2009_08_006
crossref_primary_10_1016_j_jvoice_2022_11_035
crossref_primary_10_1007_s11605_014_2574_5
crossref_primary_10_1053_j_jvca_2017_04_045
crossref_primary_10_1155_2015_734857
crossref_primary_10_1097_00003246_200301000_00036
crossref_primary_10_1002_glia_22399
crossref_primary_10_3389_fimmu_2021_698121
crossref_primary_10_1097_CCM_0000000000002649
crossref_primary_10_1007_s11739_022_03077_8
crossref_primary_10_1080_10739680600777599
crossref_primary_10_1212_01_CON_0000300029_68650_8f
crossref_primary_10_1097_01_TA_0000025584_46870_95
crossref_primary_10_1097_CCE_0000000000000392
crossref_primary_10_1590_S1806_37132011000100013
crossref_primary_10_3109_00365548_2012_760844
crossref_primary_10_1152_ajpheart_00706_2003
crossref_primary_10_1152_ajplung_00337_2020
crossref_primary_10_1186_CC11355
crossref_primary_10_1007_s12016_017_8648_x
crossref_primary_10_1097_GME_0000000000000864
crossref_primary_10_1097_01_shk_0000191341_31530_5e
crossref_primary_10_1007_s10903_022_01413_w
crossref_primary_10_1016_j_jss_2004_04_020
crossref_primary_10_1111_j_1537_2995_2012_03618_x
crossref_primary_10_3390_life14050561
crossref_primary_10_1080_23744235_2021_1900906
crossref_primary_10_1113_JP286216
crossref_primary_10_1097_CCM_0b013e31819da853
crossref_primary_10_1016_S1521_6616_02_00025_6
crossref_primary_10_1080_13685530500233847
crossref_primary_10_1371_journal_pone_0281939
crossref_primary_10_1038_s41598_023_27506_6
crossref_primary_10_1097_01_CCM_0000186748_64438_7B
crossref_primary_10_1007_s00101_006_0983_x
crossref_primary_10_1136_heartjnl_2021_319254
crossref_primary_10_1097_01_shk_0000177639_22863_99
crossref_primary_10_1186_cc12570
crossref_primary_10_1097_SHK_0000000000000226
crossref_primary_10_1007_s00423_002_0346_2
crossref_primary_10_1002_jmv_27075
crossref_primary_10_1007_s12018_018_9253_0
crossref_primary_10_1089_109629603764655263
crossref_primary_10_1016_j_nut_2008_03_015
crossref_primary_10_1152_ajplung_00302_2004
crossref_primary_10_1111_j_1748_1716_2011_02334_x
crossref_primary_10_1016_j_bbi_2015_08_013
crossref_primary_10_1089_sur_2023_154
crossref_primary_10_1097_TA_0000000000000251
crossref_primary_10_1002_jnr_23831
crossref_primary_10_1152_ajpcell_2000_278_3_C509
crossref_primary_10_1254_fpj_23040
crossref_primary_10_1097_01_shk_0000239767_64786_de
crossref_primary_10_1111_j_1365_277X_2010_01064_x
crossref_primary_10_1016_j_athoracsur_2008_02_082
crossref_primary_10_1016_j_surg_2005_03_016
crossref_primary_10_1016_S1550_8579_07_80061_1
crossref_primary_10_1080_00365521_2021_2002927
crossref_primary_10_1039_C5FO01357G
crossref_primary_10_1186_s43044_020_0039_6
crossref_primary_10_1080_02688697_2022_2064430
crossref_primary_10_1038_s41598_024_52735_8
crossref_primary_10_1016_j_jcrc_2014_03_021
crossref_primary_10_1016_j_surg_2005_03_020
crossref_primary_10_1016_S0002_9343_01_00771_9
crossref_primary_10_1016_j_metabol_2023_155400
crossref_primary_10_1007_BF03339893
crossref_primary_10_1242_dmm_008052
crossref_primary_10_1186_s13293_015_0035_9
crossref_primary_10_1186_cc13132
crossref_primary_10_1097_01_CCM_0000256839_50053_1D
crossref_primary_10_3892_mmr_2015_3394
crossref_primary_10_1152_ajpcell_00467_2004
crossref_primary_10_1177_24705470211032208
crossref_primary_10_1097_CCM_0b013e3181ad7654
crossref_primary_10_1007_s00423_006_0127_4
crossref_primary_10_1016_S0020_1383_02_00018_9
crossref_primary_10_1089_jwh_2013_4434
crossref_primary_10_1111_bph_12063
crossref_primary_10_1097_TA_0b013e31816543dd
crossref_primary_10_1159_000073775
crossref_primary_10_1007_s12035_019_01681_y
crossref_primary_10_1016_S1885_5857_10_70285_1
crossref_primary_10_1097_SHK_0b013e3181506ee5
crossref_primary_10_1016_j_ejphar_2018_01_051
crossref_primary_10_1016_j_jinf_2022_04_035
crossref_primary_10_1016_j_trsl_2007_12_008
crossref_primary_10_1186_cc1067
crossref_primary_10_1016_j_vetimm_2015_06_009
crossref_primary_10_1186_s13293_018_0187_5
crossref_primary_10_4161_viru_27045
crossref_primary_10_4049_jimmunol_179_9_6284
crossref_primary_10_3389_fimmu_2019_01052
crossref_primary_10_1097_01_ta_0000174941_53688_01
crossref_primary_10_1097_01_shk_0000142552_77473_7d
crossref_primary_10_3748_wjg_14_2818
crossref_primary_10_1097_SLA_0b013e318148566
crossref_primary_10_1007_s00268_007_9193_1
crossref_primary_10_1097_CCE_0000000000000433
crossref_primary_10_1097_01_shk_0000144134_03598_c5
crossref_primary_10_3390_v15122354
crossref_primary_10_4037_ajcc2013225
crossref_primary_10_1345_aph_1Q319
crossref_primary_10_1007_BF02738619
crossref_primary_10_4266_kjccm_2009_24_1_28
crossref_primary_10_1016_j_ijdevneu_2018_07_012
crossref_primary_10_1007_s11845_019_02162_w
crossref_primary_10_1089_sur_2012_211
crossref_primary_10_3389_fimmu_2021_706583
crossref_primary_10_1097_01_shk_0000183388_90895_cb
crossref_primary_10_1152_ajplung_00123_2021
crossref_primary_10_1097_TA_0000000000001157
crossref_primary_10_1016_j_jcrc_2018_10_017
crossref_primary_10_1007_s00540_012_1425_3
crossref_primary_10_1042_CS20140840
crossref_primary_10_1152_physrev_00037_2012
crossref_primary_10_1902_jop_2010_100045
crossref_primary_10_3109_14767058_2012_684165
crossref_primary_10_1016_j_burns_2009_06_212
crossref_primary_10_1097_CM9_0000000000000392
crossref_primary_10_3748_wjg_15_5604
crossref_primary_10_15406_ghoa_2018_09_00306
crossref_primary_10_3389_fendo_2023_1152634
crossref_primary_10_1590_1519_6984_249125
crossref_primary_10_1017_S031716710005335X
crossref_primary_10_1177_11297298231225808
crossref_primary_10_1016_j_jss_2005_04_015
crossref_primary_10_1016_j_surg_2003_08_012
crossref_primary_10_3390_jcm8081263
crossref_primary_10_1007_s10354_020_00787_6
crossref_primary_10_1093_cid_civ576
crossref_primary_10_1016_j_jss_2005_04_017
crossref_primary_10_1097_00024382_200207000_00005
crossref_primary_10_5812_traumamon_38083
crossref_primary_10_1016_j_autrev_2011_12_004
crossref_primary_10_1210_en_2009_0098
crossref_primary_10_1097_00024382_200210000_00004
crossref_primary_10_1167_iovs_61_14_5
crossref_primary_10_1016_j_jss_2004_12_009
crossref_primary_10_1089_109629601317202713
crossref_primary_10_1016_j_jcrc_2019_11_002
crossref_primary_10_1080_23744235_2018_1511056
crossref_primary_10_1097_CCM_0b013e318186f556
crossref_primary_10_1097_01_CCM_0000256845_92640_38
crossref_primary_10_4103_0972_5229_56052
crossref_primary_10_1016_j_jneuroim_2008_08_005
crossref_primary_10_1016_j_jcrc_2014_01_002
crossref_primary_10_1002_jor_25116
crossref_primary_10_2217_17410541_5_3_249
crossref_primary_10_1016_j_pupt_2011_07_002
crossref_primary_10_1097_01_shk_0000232589_39001_4d
crossref_primary_10_1007_s12630_011_9629_9
crossref_primary_10_1016_S0899_5885_02_00028_X
crossref_primary_10_1097_CCM_0b013e3182a84a43
crossref_primary_10_1097_CCM_0b013e3181760c14
crossref_primary_10_3892_mmr_2016_5112
crossref_primary_10_1177_1538574411403167
crossref_primary_10_1007_s00134_008_1313_3
crossref_primary_10_1155_2011_819724
crossref_primary_10_1128_IAI_72_7_4282_4285_2004
crossref_primary_10_1016_j_jri_2006_01_004
crossref_primary_10_1155_2017_5216562
crossref_primary_10_1080_09712119_2014_883318
crossref_primary_10_1186_s12873_024_00934_x
crossref_primary_10_1016_j_jcrc_2022_153985
crossref_primary_10_7759_cureus_12844
crossref_primary_10_1155_2013_928290
crossref_primary_10_1186_s40560_016_0205_9
crossref_primary_10_1373_clinchem_2004_032144
crossref_primary_10_1016_S0002_9610_00_00298_1
crossref_primary_10_1186_s12929_024_01043_4
crossref_primary_10_1177_1099800404263014
crossref_primary_10_1371_journal_pone_0224278
crossref_primary_10_1097_PCC_0b013e31823c980f
crossref_primary_10_1016_j_imlet_2019_01_002
crossref_primary_10_1016_j_jss_2008_08_035
crossref_primary_10_1186_s13293_023_00501_2
crossref_primary_10_1517_14728222_2015_1057570
crossref_primary_10_1016_j_bbi_2021_11_007
crossref_primary_10_1053_jvet_2002_34661
crossref_primary_10_1007_s00540_012_1426_2
crossref_primary_10_1097_01_CCM_0000262946_68003_21
crossref_primary_10_1371_journal_pone_0251317
crossref_primary_10_1164_rccm_200603_341OC
crossref_primary_10_3390_jcm9072287
crossref_primary_10_1097_SHK_0000000000000939
crossref_primary_10_3389_fpubh_2020_00418
crossref_primary_10_1155_2018_6964529
crossref_primary_10_1016_j_jiac_2015_11_007
crossref_primary_10_1093_jn_134_10_2768S
crossref_primary_10_1016_j_amjsurg_2003_07_022
crossref_primary_10_1097_SLA_0000000000000789
crossref_primary_10_1002_bies_201100047
crossref_primary_10_1089_ars_2021_0056
crossref_primary_10_1590_S1807_59322006000500017
crossref_primary_10_1667_RR1295_1
crossref_primary_10_1097_TA_0b013e31822c0d31
crossref_primary_10_1089_sur_2007_037
crossref_primary_10_1097_00001503_199904000_00003
crossref_primary_10_1097_HP_0b013e31824
crossref_primary_10_1016_S0025_7125_05_70157_7
crossref_primary_10_1016_S1550_8579_05_80007_5
crossref_primary_10_3389_fimmu_2024_1379754
crossref_primary_10_1002_emmm_201201375
crossref_primary_10_1182_blood_2003_02_0649
crossref_primary_10_1152_ajpcell_00134_2022
crossref_primary_10_1016_S0092_8674_04_00131_X
crossref_primary_10_1097_00003246_200107000_00002
crossref_primary_10_1002_crt2_9
crossref_primary_10_1016_j_fsi_2016_11_057
crossref_primary_10_4103_jiaps_jiaps_156_21
crossref_primary_10_3390_ijms23169312
crossref_primary_10_1016_j_bbi_2009_02_019
crossref_primary_10_1590_S0102_86502004000200006
crossref_primary_10_1016_j_jss_2005_02_019
crossref_primary_10_1097_00005373_200211000_00013
crossref_primary_10_1097_00024382_200301000_00006
crossref_primary_10_1152_ajpgi_00036_2004
crossref_primary_10_4236_ss_2020_1111038
crossref_primary_10_1152_japplphysiol_00182_2003
crossref_primary_10_1016_j_injury_2014_08_013
crossref_primary_10_1038_sj_bjc_6601541
crossref_primary_10_3390_ijerph19158895
crossref_primary_10_1097_SHK_0b013e3182571e46
crossref_primary_10_1097_01_CCM_0000190242_24410_17
crossref_primary_10_1016_S0031_9384_01_00569_8
crossref_primary_10_1097_shk_0b013e31805cdc96
crossref_primary_10_1164_rccm_200207_682OC
crossref_primary_10_1016_j_jneuroim_2013_05_004
crossref_primary_10_1164_rccm_200404_446OC
crossref_primary_10_1093_jn_nxaa318
crossref_primary_10_1007_s11884_015_0301_z
crossref_primary_10_1016_j_archoralbio_2010_09_008
crossref_primary_10_1097_01_CCM_0000292015_16171_6D
crossref_primary_10_1152_ajpregu_00605_2005
crossref_primary_10_1016_j_ccc_2005_08_005
crossref_primary_10_1016_j_surg_2004_04_037
crossref_primary_10_1038_s41598_022_23443_y
crossref_primary_10_1186_s13104_019_4353_6
crossref_primary_10_3109_03009734_2012_703255
crossref_primary_10_1007_s00423_007_0152_y
crossref_primary_10_1016_S0002_9610_01_00582_7
crossref_primary_10_1097_ACO_0b013e32835d7160
crossref_primary_10_1152_ajpendo_00485_2004
crossref_primary_10_1016_j_alcohol_2004_05_005
crossref_primary_10_1016_j_fjs_2012_10_003
crossref_primary_10_1097_00003246_200203000_00028
crossref_primary_10_1016_j_urology_2014_11_025
crossref_primary_10_1016_S0300_8932_10_70281_5
crossref_primary_10_1371_journal_pone_0051457
crossref_primary_10_2147_JIR_S335203
crossref_primary_10_1097_01_CCM_0000253810_08230_83
crossref_primary_10_1016_j_amjsurg_2005_03_031
crossref_primary_10_4236_ojim_2015_53008
crossref_primary_10_1378_chest_07_0420
crossref_primary_10_1016_j_psychres_2017_05_022
crossref_primary_10_1080_00365540600993285
crossref_primary_10_1111_j_1582_4934_2009_00669_x
crossref_primary_10_1177_1754073917709940
ContentType Journal Article
Copyright Copyright American Medical Association Nov 1998
Copyright_xml – notice: Copyright American Medical Association Nov 1998
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
K9.
NAPCQ
7X8
DOI 10.1001/archsurg.133.11.1200
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
ProQuest Health & Medical Complete (Alumni)

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1538-3644
2168-6262
EndPage 1205
ExternalDocumentID 35897431
10_1001_archsurg_133_11_1200
9820351
211838
Genre Journal Article
Comparative Study
GroupedDBID ---
-QF
.55
.XZ
23N
2WC
354
39C
3O-
4.4
53G
5GY
6J9
AAWTL
AAYEP
ABCQX
ABJNI
ABOCM
ACGFO
ACGFS
ADBBV
AFFNX
ALMA_UNASSIGNED_HOLDINGS
AMJDE
ARBJA
BRYMA
C1A
C45
CS3
EAM
EBS
EJD
EMOBN
EX3
F5P
GX1
IH2
J5H
L7B
N4W
N9A
OB2
OBH
OHH
OVD
P2P
RAJ
RXW
SJN
SV3
TEORI
VVN
WH7
WOW
X6Y
X7M
XHN
YOC
ZA5
ZE2
ZGI
ZXP
ZY1
2CT
AI.
CGR
CUY
CVF
ECM
EIF
NPM
RWL
TAE
VH1
AAYXX
CITATION
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-a393t-1dc5af1c829e62d54499e650d4a29df85766f05d58f9b379be42ecc7a5829503
ISSN 0004-0010
2168-6254
IngestDate Sat Aug 17 01:17:53 EDT 2024
Thu Oct 10 18:38:34 EDT 2024
Fri Aug 23 04:07:45 EDT 2024
Sat Sep 28 08:36:16 EDT 2024
Fri Jul 05 02:03:44 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 11
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-a393t-1dc5af1c829e62d54499e650d4a29df85766f05d58f9b379be42ecc7a5829503
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doi.org/10.1001/archsurg.133.11.1200
PMID 9820351
PQID 232557787
PQPubID 42213
PageCount 6
ParticipantIDs proquest_miscellaneous_70074731
proquest_journals_232557787
crossref_primary_10_1001_archsurg_133_11_1200
pubmed_primary_9820351
ama_primary_211838
PublicationCentury 1900
PublicationDate 1998-11-01
PublicationDateYYYYMMDD 1998-11-01
PublicationDate_xml – month: 11
  year: 1998
  text: 1998-11-01
  day: 01
PublicationDecade 1990
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Chicago
PublicationTitle Archives of surgery (Chicago. 1960)
PublicationTitleAlternate Arch Surg
PublicationYear 1998
Publisher American Medical Association
Publisher_xml – name: American Medical Association
References 10896386 - Arch Surg. 2000 Jul;135(7):875
References_xml
SSID ssj0012892
Score 1.8106261
Snippet BACKGROUND In animal studies, gender differences were related to hormonal and immunologic changes that were associated with an increased susceptibility to...
In animal studies, gender differences were related to hormonal and immunologic changes that were associated with an increased susceptibility to sepsis in...
BACKGROUND: In animal studies, gender differences were related to hormonal and immunologic changes that were associated with an increased susceptibility to...
BACKGROUNDIn animal studies, gender differences were related to hormonal and immunologic changes that were associated with an increased susceptibility to...
SourceID proquest
crossref
pubmed
ama
SourceType Aggregation Database
Index Database
Publisher
StartPage 1200
SubjectTerms APACHE
Estradiol - blood
Female
Hospital Mortality
Humans
Interleukin-10 - blood
Interleukin-6 - blood
Male
Middle Aged
Multiple Organ Failure - etiology
Postoperative Complications - blood
Postoperative Complications - immunology
Prognosis
Prospective Studies
Sepsis - blood
Sepsis - complications
Sepsis - immunology
Sex Characteristics
Survival Analysis
Testosterone - blood
Tumor Necrosis Factor-alpha - metabolism
Title Gender Differences in Human Sepsis
URI http://dx.doi.org/10.1001/archsurg.133.11.1200
https://www.ncbi.nlm.nih.gov/pubmed/9820351
https://www.proquest.com/docview/232557787
https://search.proquest.com/docview/70074731
Volume 133
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLfKuHBBTDBRNiBC3FBKHcf5OCK0UU1jHMhQxcWyHVubNCVT01721_NLnLjpNhBwiSK7deT3nn9-z34fhLxXxmqo3Ta0OZ-HQMk0lIzpkGqdKcBhGas23vnrebK4iE-XfDmZ3I6jS9Zqpm8fjCv5H66iDXxto2T_gbN-UDTgHfzFExzG86947OrA-SInzrmqL7vXmJvmqhnrnuMks42Lhu7ucJ0zxuwDVsl8dDDwXV-u6tJx9LTu82C10Cwvr51Hz48aL6tt--o6XLRAX3VVgTdKan_W_FMq5w6w9Qcufewd3TlquHeHdFeCOtiKaJKFsKrcMYEZt93BXZcBYxAwOoJR6tKX3sd3V1egC9oBnWYYApg_G36-m077_Js4uTg7E8Xxstjtdds3z_JWfXpEHkcAqRYdvyy9exC27a6gtp-ND7ukHx_6_DhR76Dc_MZi6TSX4hl52pscwScnP_tkYqrn5J2TnWAkO8FVFXSyEzjZeUGKk-Pi8yLs62VgeeVsHdJSc2mpzqLcJFHJY1izBhp4GcsoL20G0zKxc17yzOaKpbkycYQVnEqOf_A5OyB7VV2ZlySgqUYf03EmZWxsrGLLoItDPSyptImZkn3MVty4hCgigpXKsikJh8n7HpcUm4qBZAIkg9EpWpJNyeFAIdEvqkZAwec8xS4yJW99LxCvvcaSlak3jUi7og-MTsmBI6v_Wg51lnH66o8DH5InW9k-Invr1ca8hmK5Vm86CfgFA3F12A
link.rule.ids 315,783,787,27936,27937
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gender+differences+in+human+sepsis&rft.jtitle=Archives+of+surgery+%28Chicago.+1960%29&rft.au=Schroder%2C+Jorg&rft.au=Kahlke%2C+Volker&rft.au=Karl-Hermann+Staubach&rft.au=Zabel%2C+Peter&rft.date=1998-11-01&rft.pub=American+Medical+Association&rft.issn=2168-6254&rft.eissn=2168-6262&rft.volume=133&rft.issue=11&rft.spage=1200&rft_id=info:doi/10.1001%2Farchsurg.133.11.1200&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=35897431
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0004-0010&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0004-0010&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0004-0010&client=summon